StockVS

Jackson Acquisition Company II (JACS) Stock Analysis

Financial Services

Jackson Acquisition Company II

$10.61

+$0.00 (+0.00%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Jackson Acquisition Company II operates within the Financial Services sector, specifically functioning as a shell company with no significant ongoing operations. The entity is structured to effect a future business combination, aiming to merge with or acquire one or more businesses or entities within the healthcare industry through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar transaction. The company's current market capitalization stands at $311.58M, while its annual revenue is not available in the provided financial data, and the number of employees is listed as N/A. These valuation metrics indicate that the company is priced based on its potential for a future transaction rather than current operational earnings, as the lack of revenue and employee data suggests the business model has not yet been established through traditional service delivery.

Financial Health

The company reports a net income of $9.12M for the trailing twelve months, while revenue and EBITDA figures are not available for reporting. The gap between the reported net income of $9.12M and the non-existent revenue data reveals a complex cost structure typical of shell companies, where income may stem from non-operating sources or accounting adjustments rather than core business activities. Free cash flow is reported at $-298,680, which indicates that the company is currently consuming cash reserves rather than generating liquidity from operations, limiting its immediate financial flexibility for independent ventures. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which indicates that the company has not yet generated revenue to create a profit on sales or covered its operating costs. The company holds $521,776 in cash against $198,024 in debt, resulting in a debt-to-equity ratio of 89.70, which suggests a leveraged balance sheet relative to its equity base despite holding more cash than debt. The current ratio stands at 1.53, indicating that the company possesses sufficient short-term assets to cover its short-term liabilities, providing a baseline level of liquidity. Return on Equity is exceptionally high at 1804.0%, while Return on Assets is negative at -0.1%, revealing that management effectiveness is currently skewed by the asset-light shell structure and the negative impact of non-operational assets on the total asset base.

Valuation Assessment

The trailing twelve-month P/E ratio is 33.97, whereas the forward P/E is not available; this discrepancy implies that analysts cannot project a forward earnings trajectory because the company lacks the historical earnings consistency required to model future performance. The price-to-book ratio is listed at 1504.29, which indicates a substantial market premium over the company's book value, a characteristic common for pre-business combination shell companies where the market price reflects the potential value of a future merger rather than current tangible assets. Neither the price-to-sales ratio nor the EV/EBITDA is available, as the company has not yet generated sales or operating earnings, meaning these alternative valuation metrics cannot be applied to assess the company's intrinsic value. The stock has traded between a 52-week high of $10.58 and a 52-week low of $10.05, placing the current trading range very close to the lower bound of the recent price history. The beta value is not available, which means there is no data to quantify the company's price volatility relative to the broader market, leaving investors unable to gauge systemic risk exposure based on historical market movements.

Growth & Income

Revenue growth and earnings growth rates are both not available due to the lack of historical revenue data and the current status of the company as a pre-transaction entity. Since the company does not generate revenue from operations, earnings cannot grow faster or slower than revenue in a traditional sense, as the metrics are currently undefined by operational activity. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates that the company reinvests its earnings, if any, or capital into the pursuit of a business combination rather than distributing income to shareholders. The overall growth and income profile is currently defined by the anticipation of a future business combination rather than historical financial performance or current cash generation.

Peer Comparison

Jackson Acquisition Company II (JACS) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Jackson Acquisition Company II JACS $313.95M 35.4
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

The Shell Companies industry average P/E ratio is 82.8x. Jackson Acquisition Company II trades at a P/E of 35.4.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Jackson Acquisition Company II

Jackson Acquisition Company II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2024 and is based in Alpharetta, Georgia.

Visit website →

Key Statistics

Market Cap
$313.95M
P/E Ratio
35.37
52-Week High
$10.65
52-Week Low
$10.08
Avg Volume
32.25K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States